POLARIS PARTNERS GP VIII, L.L.C. purchased 48.5% of their position (36.11K shares) of PANDION THERAPEUTICS, INC. on the open market
Open‑market purchase worth $650.0K — a major conviction buy. The strongest form of insider conviction signal.
Common Stock
Shares
+2.78M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+272.05K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+99.64K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+9.74K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+34.86K
Price / share
$18.00
Trade value
$627.53K
% of position
Common Stock
Shares
+1.25K
Price / share
$18.00
Trade value
$22.46K
% of position
Net shares
+3.20M
Net value
$650K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/21/2020 | C · Conversion | +2.78M | — | — | New position | 0.00 | 2.78M |
| Common Stock Indirect | 7/21/2020 | C · Conversion | +272.05K | — | — | 9.8% | 2.78M | 3.06M |
| Common Stock Indirect | 7/21/2020 | C · Conversion | +99.64K | — | — | New position | 0.00 | 99.64K |
| Common Stock Indirect | 7/21/2020 | C · Conversion | +9.74K | — | — | 9.8% | 99.64K | 109.37K |
| Common Stock Indirect | 7/21/2020 | P · Purchase | +34.86K | $18.00 | $627.53K | 1.1% | 3.06M | 3.09M |
| Common Stock Indirect | 7/21/2020 | P · Purchase | +1.25K | $18.00 | $22.46K | 1.1% | 109.37K | 110.62K |
| Total | +3.20M | $650K | ||||||
Series A Preferred Stock
Common Stock
2.78M shares
Shares
−14.20M
Strike price
Held after
0.00
Exercisable
—
Series A Preferred Stock
Common Stock
99.64K shares
Shares
−508.09K
Strike price
Held after
0.00
Exercisable
—
Series B Preferred Stock
Common Stock
272.05K shares
Shares
−1.39M
Strike price
Held after
0.00
Exercisable
—
Series B Preferred Stock
Common Stock
9.74K shares
Shares
−49.65K
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Preferred Stock Indirect | Common Stock2.78M shares | 7/21/2020 | C · Conversion | −14.20M | — | 0.00 | |
| Series A Preferred Stock Indirect | Common Stock99.64K shares | 7/21/2020 | C · Conversion | −508.09K | — | 0.00 | |
| Series B Preferred Stock Indirect | Common Stock272.05K shares | 7/21/2020 | C · Conversion | −1.39M | — | 0.00 | |
| Series B Preferred Stock Indirect | Common Stock9.74K shares | 7/21/2020 | C · Conversion | −49.65K | — | 0.00 |